Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0669-2017Class II

MISAGO RX Self Expanding Peripheral Stem

Terumo Medical Corp. / initiated 2016-08-04 / Terminated / root cause: design

Terumo Medical Corp began a recall of MISAGO RX Self Expanding Peripheral Stem on . FDA classified it as Class II and gives the reason as "During recent routine testing, the MISAGO Peripheral Stent was found not to conform to product specification related to stent diameter at the proximal/distal ends and/or the shape of the stent". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-0669-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Terumo Medical Corp.
Product
MISAGO RX Self Expanding Peripheral Stem
Product code
NIP Stent, Superficial Femoral Artery
Reason for recall
During recent routine testing, the MISAGO Peripheral Stent was found not to conform to product specification related to stent diameter at the proximal/distal ends and/or the shape of the stent.
Root cause tag
design
FDA root cause
Device Design
Action
Terumo Medical Corporation issued an Urgent Product Recall Bulletin dated August 4, 2016, via Fed Ex. Customers must immediately discontinue use and quarantine any available stock of the Misago peripheral stent to prevent further use. The customers should complete the enclosed Inventory Confirmation form as soon as possible and email or fax the completed form to [email protected] or (734) 330-2034, Attn: MISAGO Recall. Customers are encourage you to contact Terumo Medical Corporation with any questions or concerns -Terumo Medical Corporation Quality Department: 1.800.283.7866, Press 4 for list of departments, Press 7 for Quality Assurance; Monday Friday, 8 a.m. 5 p.m. ET - Email Quality Assurance: [email protected] - Customer Care: 1.800.888.3786 - Contact your local Terumo representative
Quantity in commerce
7,965 units
Distribution
Nationwide
Product codes and lots
150401 150429 150713 150821 150923 151009 160314  150413 150501 150708 150824 150915 151013 151111  150415 150515 150701 150716 150902 151005 151106  150407 150514 150707 150827 151008 151109 160509  150406 150501 150713 150716 150825 151001 151102 160315 160509 150410 150710 150831 150909 151007 151012 151014 151103 151208 150417 150429 150717 150910 151002 151102 160510  150408 150429 150701 150717 150831 151013 151103 160512  150409 150430 150518 150703 150706 150903 150914 151005  150331 150430 150708 150714 150904 150910 151001 151102  150414 150429 150715 150903 151005 151029 160323  150416 150518 150715 150908 150915 151002 151106 160328  150401 150430 150716 150828 151006  150403 150514 150717 150901 150909 151012  150408 150430 150713 150907 151001  150402 150512 150713 150907 151001

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0669-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0669-2017Class IITerminatedVoluntary: Firm initiated